Local, state and federal regulations, combined with new taxes and health warnings, add pressure to c-store tobacco and nicotine sales in 2022. Where is the FDA in its process to assess/approve/deny applications for new products? Are tax increases driving your customers across state lines? Is CBD steady, growing or declining? Cannabis has been in the wings, as regulation varies from state to state and awaits federal action. Uncertainty still reigns in this category that remains the top sales and profit generator in the c-store channel.